AIM2 |
AIM2 inflammasome complex |
GO:0097169 |
AIM2 |
cytoplasm |
GO:0005737 |
AIM2 |
cytosol |
GO:0005829 |
AIM2 |
mitochondrion |
GO:0005739 |
AIM2 |
nucleoplasm |
GO:0005654 |
AIM2 |
double-stranded DNA binding |
GO:0003690 |
AIM2 |
identical protein binding |
GO:0042802 |
AIM2 |
activation of innate immune response |
GO:0002218 |
AIM2 |
apoptotic process |
GO:0006915 |
AIM2 |
cellular response to drug |
GO:0035690 |
AIM2 |
cellular response to interferon-beta |
GO:0035458 |
AIM2 |
immune response |
GO:0006955 |
AIM2 |
inflammatory response |
GO:0006954 |
AIM2 |
innate immune response |
GO:0045087 |
AIM2 |
interleukin-1 beta secretion |
GO:0050702 |
AIM2 |
negative regulation of NF-kappaB transcription factor activity |
GO:0032088 |
AIM2 |
NLRP3 inflammasome complex assembly |
GO:0044546 |
AIM2 |
positive regulation of cysteine-type endopeptidase activity |
GO:2001056 |
AIM2 |
positive regulation of defense response to virus by host |
GO:0002230 |
AIM2 |
positive regulation of interleukin-1 beta production |
GO:0032731 |
AIM2 |
positive regulation of interleukin-1 beta secretion |
GO:0050718 |
AIM2 |
positive regulation of NF-kappaB transcription factor activity |
GO:0051092 |
AIM2 |
pyroptosis |
GO:0070269 |
AIM2 |
pyroptosome complex assembly |
GO:1904270 |
AIM2 |
tumor necrosis factor-mediated signaling pathway |
GO:0033209 |